Molecular structure of Tenoxicam, CAS Number: 59804-37-4
Tenoxicam (CAS 59804-37-4)
Application:
Tenoxicam is a nonsteroidal, anti-inflammatory, analgesic agent
CAS Number:
59804-37-4
Molecular Weight:
337.38
Molecular Formula:
C13H11N3O4S2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Tenoxicam is a compound that inhibits the activity of the enzyme cyclooxygenase, which is involved in the production of prostaglandins. Prostaglandins are lipid compounds that play a key role in the inflammatory response. This may be useful in the study of inflammatory processes and pain pathways in biochemistry. It is used as a reference compound in studies investigating the effects of NSAIDs on prostaglandin production and inflammation. In biochemistry, tenoxicam is for understanding the molecular mechanisms underlying inflammation and pain, and it is used to investigate the biochemistry of NSAIDs and their effects on prostaglandin synthesis.
Tenoxicam (CAS 59804-37-4) References
- Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. | Todd, PA. and Clissold, SP. 1991. Drugs. 41: 625-46. PMID: 1711963
- Single dose oral tenoxicam for acute postoperative pain in adults. | Moore, OA., et al. 2009. Cochrane Database Syst Rev. 2009: CD007591. PMID: 19588438
- Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs). | Schmitt, M. and Guentert, TW. 1989. Scand J Rheumatol Suppl. 80: 86-9. PMID: 2688082
- An innovative role for tenoxicam as a quorum sensing inhibitor in Pseudomonas aeruginosa. | Askoura, M., et al. 2020. Arch Microbiol. 202: 555-565. PMID: 31732766
- Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. | Gonzalez, JP. and Todd, PA. 1987. Drugs. 34: 289-310. PMID: 3315620
- Clinical experience with tenoxicam: a review. | Bird, HA. 1987. Scand J Rheumatol Suppl. 65: 102-6. PMID: 3317799
- Efficacy and tolerability of tenoxicam--an overview. | Vischer, TL. 1987. Scand J Rheumatol Suppl. 65: 107-12. PMID: 3317800
- Overview on the pharmacokinetics of tenoxicam. | Guentert, TW., et al. 1987. Eur J Rheumatol Inflamm. 9: 15-25. PMID: 3329107
- Efficacy and tolerability of tenoxicam--an overview. | Vischer, TL. 1987. Eur J Rheumatol Inflamm. 9: 51-7. PMID: 3329109
- Tenoxicam loaded hyalcubosomes for osteoarthritis. | Elakkad, YE., et al. 2021. Int J Pharm. 601: 120483. PMID: 33737098
- Tenoxicam and renal function. | Heintz, RC. 1995. Drug Saf. 12: 110-9. PMID: 7766336
- Clinical pharmacokinetics of tenoxicam. | Nilsen, OG. 1994. Clin Pharmacokinet. 26: 16-43. PMID: 8137596
- Tenoxicam-associated hepatic injury: a case report and review. | Katsinelos, P., et al. 1997. Eur J Gastroenterol Hepatol. 9: 403-6. PMID: 9160206
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Tenoxicam, 250 mg | sc-205856 | 250 mg | $64.00 | |||
Tenoxicam, 1 g | sc-205856A | 1 g | $200.00 |